More than one-third of patients receiving HIV medication in Africa die or discontinue their treatment within two years, according to a study published in PLoS Medicine.
Merck & Co., Inc., announced that the U.S. Food and Drug Administration (FDA) granted ISENTRESS TM (raltegravir) tablets accelerated approval for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in treatment-experienced adult patients who have evidence of viral replication and HIV-1 strains resistant to multiple antiretroviral agents.
The Indian Minister of State for Health & Family Welfare, Smt. Panabaka Lakshmi launched the Joint UN Programme on HIV and AIDS Prevention and Care in the North-Eastern States. This is a unique endeavour, which demonstrates a strong partnership between the Government of India, the UN system and the donors, the Governments of Australia and Sweden to improve the quality of and augment response to the HIV epidemic in North-East India.
Male sex tourists, largely from the United States and Europe, may be fueling an HIV/AIDS epidemic in the Caribbean, and efforts to stop the epidemic will be severely hampered unless HIV prevention dollars are diverted to help male prostitutes, a new study suggests.
At the Keystone Symposium in Cape Town, the Global HIV Vaccine Enterprise announced the appointment of its first executive director and the opening of a new secretariat in New York City. Dr. Alan Bernstein, founding president of the Canadian Institutes of Health Research, will lead the international alliance of researchers, funders and advocates dedicated to speeding the search for an HIV vaccine.
October 15, 2007, marks the fifth annual National Latino AIDS Awareness Day. On this day, the National Institute of Allergy and Infectious Diseases (NIAID) pledges to continue working toward reducing the burden of HIV/AIDS in the Latino community in the United States.
There has been an alarming rise in the number of HIV patients in Bhutan, with the Health Ministry detecting about 20 cases this year.
A combination of drugs widely used to treat infections caused by HIV appears to stop brain damage caused by the virus as well, according to a study published in the Oct. 9, 2007, issue of Neurology, the medical journal of the American Academy of Neurology.
A team led by researchers at the UCSF Positive Health Program has been named to receive $15 million over five years to expand understanding of the complex interactions between HIV and the immune systems of newly infected patients following HIV transmission.
Although there has been a decrease in the prevalence of HIV, the Department of Health is intensifying its HIV prevention programme including the improvement of regimen for Prevention of Mother-To-Child Transmission of HIV (PMTCT), said Health Minister, Dr Manto Tshabalala-Msimang.